Inställningar

Split view

Short keys for navigating in split view

↑	Select newer press release
↓	Select older press release
←	Navigate backwards
→	Navigate forward
Enter	Navigate to line in focus
Tab	Focus next link
A or 1	Open First attachment
S or 2	Open Second attachment
D or 3	Open Third attachment
F or 4	Open Fourth attachment
I	Show company information
PgUp	Select newest press release
PgDown	Select oldest press release
L	Focus on filer bar
N	Increase preview window size
M	Decrease preview window size
Esc	Escape from mode

Dark Mode

Set dark mode to MFN.se

Sound

Plays a notification sound when new press release is published in the current feed

Intresserad av platformen MFN för nyhetsdistribution?

Fredag 28 Augusti | 03:42:32 Europe / Stockholm

Svenska | English

Panion Animal Health

Bifogade filer

PDF

Kalender

	Est. tid*
2019-11-21	-	Kvartalsrapport 2019-Q3
2019-09-30	-	15-6 2019
2019-09-06	-	Extra Bolagsstämma 2019
2019-08-29	-	Kvartalsrapport 2019-Q2
2019-05-22	-	Kvartalsrapport 2019-Q1
2019-05-10	-	X-dag ordinarie utdelning PANION 0.00 SEK
2019-04-23	-	Årsstämma
2019-02-22	-	Bokslutskommuniké 2018
2018-11-22	-	Kvartalsrapport 2018-Q3
2018-08-22	-	Kvartalsrapport 2018-Q2
2018-05-30	-	X-dag ordinarie utdelning PANION 0.00 SEK
2018-05-29	-	Årsstämma
2018-05-18	-	Kvartalsrapport 2018-Q1
2018-02-22	-	Bokslutskommuniké 2017
2017-11-21	-	Kvartalsrapport 2017-Q3
2017-08-21	-	Kvartalsrapport 2017-Q2

Beskrivning

Land	Sverige
Sektor	Hälsovård
Industri	Bioteknik

Panion Animal Health är specialiserade inom utveckling av genterapi för behandling av epilepsi hos hundar och övriga husdjur. Produkterna består av ett flertal veterinärmedicinska produkter och övriga behandlingsformer. Idag innehas verksamhet inom Europa och Nordamerika. Bolaget etablerades 2005 som ett dotterbolag till CombiGene. Huvudkontoret ligger i Hässleholm.

Intresserad av bolagets nyckeltal?

Analysera bolaget i Börsdata!

Vem äger bolaget?

All ägardata du vill ha finns i Holdings!

Combigene has decided to carry through the bid to shareholders in Panion

2019-07-10 20:58:15

The shareholders of Panion Animal Health AB have accepted the offer from Combigene AB with an acceptance rate below 90%. The exact number is expected to be announced tomorrow the 11.th of July 2019.

Despite not reaching the intended 90% of acceptance and with reference to the press release from Combigene AB, link (http://combigene.com/2/wp-content/uploads/2019/07/CombiGene_190710_CombiGene-concludes-the-offer.pdf), Combigene's board has decided to complete the bid and end the acceptance period and that the non-cash shares issue is carried out.

The board and management of Panion have noted the outcome of the procedure and will immediately consider and facilitate the necessary steps in the process for Panion.